LEP and type 1 diabetes mellitus: Of note, the streptozotocin-induced type 1 diabetes model is characterized by more complex metabolic changes, including drastic decrease of insulin levels and alteration of leptin signalling, which may explain the differences between our in vivo and in vitro models (MacDougald et al., 1995).